Table 2
Health care costs (2006 USD)
| Blood Level (μg/dL) | Cost of recommended medical action | Lower bound of affected children (no.) | Upper bound of affected children (no.) | Lower bound cost | Upper bound cost |
|---|---|---|---|---|---|
| 10–15 | $74 | 24,554 | 120,656 | $1,816,996 | $8,928,552 |
| 15–20 | $74 | 8,185 | 40,220 | $605,690 | $2,976,305 |
| 20–45 | $1,207 | 6,347 | 31,189 | $7,660,829 | $37,644,611 |
| 45–70 | $1,335 | 376 | 1,848 | $501,960 | $2,466,585 |
| > 70 | $3,444 | 64 | 314 | $220,416 | $1,083,104 |
| All Levels | 39,526 | 194,227 | $10,805,891 | $53,099,158 |
Note: Kemper et al. (1998) provided estimates for the costs of recommended action (inflated to 2006 USD). The upper bound values are calculated assuming that CDC state-level surveillance confirmed cases represent 20.35% of estimates > 10 μg/dL derived from NHANES (2003–2006): 39,536 confirmed cases to 194,227 cases as estimated from NHANES (2003–2006).
Previous chart: « Number of children 1–5 years old with blood lead levels at least 10 μg/dL
Next chart: Total costs and benefits of lead control (billions of 1996 dollars) »